Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 41
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Nucleic Acids Res ; 49(16): 9342-9352, 2021 09 20.
Artículo en Inglés | MEDLINE | ID: mdl-34403458

RESUMEN

Polypyrimidine tract-binding protein (PTB) is an RNA binding protein existing both as dimer and monomer and shuttling between nucleus and cytoplasm. However, the regulation of PTB dimerization and the relationship between their functions and subcellular localization are unknown. Here we find that PTB presents as dimer and monomer in nucleus and cytoplasm respectively, and a disulfide bond involving Cysteine 23 is critical for the dimerization of PTB. Additionally, protein disulfide isomerase (PDI) is identified to be the enzyme that catalyzes the de-dimerization of PTB, which is dependent on the CGHC active site of the a' domain of PDI. Furthermore, upon DNA damage induced by topoisomerase inhibitors, PTB is demonstrated to be de-dimerized with cytoplasmic accumulation. Finally, cytoplasmic PTB is found to associate with the ribosome and enhances the translation of p53. Collectively, these findings uncover a previously unrecognized mechanism of PTB dimerization, and shed light on the de-dimerization of PTB functionally linking to cytoplasmic localization and translational regulation.


Asunto(s)
Proteína de Unión al Tracto de Polipirimidina/genética , Proteína Disulfuro Isomerasas/genética , Multimerización de Proteína/genética , Proteína p53 Supresora de Tumor/genética , Células A549 , Catálisis , Dominio Catalítico/genética , Núcleo Celular/genética , Citoplasma/genética , Células HEK293 , Humanos , Proteína de Unión al Tracto de Polipirimidina/ultraestructura , Unión Proteica/genética , Dominios Proteicos/genética , Proteínas de Unión al ARN/genética , Proteína p53 Supresora de Tumor/ultraestructura
2.
Biochim Biophys Acta ; 1840(6): 1958-64, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24576672

RESUMEN

BACKGROUND: TP53 tumor suppressor gene is mutated in more than 50% of human tumors. Mutated p53 proteins could sequestrate and inactivate p73 reducing the apoptotic and anti-proliferative effects of the transcription factor, and yielding cancer cells more aggressive and chemoresistant. The possibility of using drugs to prevent the mutant p53/p73 complex formation preserving the p73 function, calls for a deeper insight into the molecular and biochemical mechanisms of mutant p53/p73 protein interaction. METHODS: The kinetics of the mutant p53R175H/p73 complex was investigated with innovative and complementary techniques, operating in real time, in near physiological conditions and without any labeling. Specifically, Atomic Force Spectroscopy and Surface Plasmon Resonance working at single-molecule level and in bulk condition, respectively, were used. RESULTS: The two techniques revealed that a stable complex is formed between mutant p53R175H and p73 proteins; the complex being characterized by a high interaction force and a dissociation equilibrium constant in the order of 10(-7)M, as expected for specific interactions. No binding was instead observed between p73 and wild type p53. CONCLUSIONS: Mutant p53R175H protein, unlike wild type p53, can form a stable complex with p73. The mutant p53R175H/p73 protein complex could be a target for innovative pharmaceutical drugs that, by dissociating it or preventing biomolecule interaction thus preserving the p73 function, could enhance the response of cancerous cells carrying mutant p53R175H protein to common chemotherapeutic agents. GENERAL SIGNIFICANCE: The kinetic information obtained in vitro may help to design specific pharmaceutical drugs directed against cancerous cells carrying mutant p53 proteins.


Asunto(s)
Proteínas de Unión al ADN/química , Microscopía de Fuerza Atómica/métodos , Proteínas Nucleares/química , Resonancia por Plasmón de Superficie/métodos , Proteína p53 Supresora de Tumor/química , Proteínas Supresoras de Tumor/química , Proteínas de Unión al ADN/ultraestructura , Humanos , Mutación , Proteínas Nucleares/ultraestructura , Proteína Tumoral p73 , Proteína p53 Supresora de Tumor/ultraestructura , Proteínas Supresoras de Tumor/ultraestructura
3.
J Biol Chem ; 288(41): 29724-35, 2013 Oct 11.
Artículo en Inglés | MEDLINE | ID: mdl-24005675

RESUMEN

In the 1960s, I developed methods for directly visualizing DNA and DNA-protein complexes using an electron microscope. This made it possible to examine the shape of DNA and to visualize proteins as they fold and loop DNA. Early applications included the first visualization of true nucleosomes and linkers and the demonstration that repeating tracts of adenines can cause a curvature in DNA. The binding of DNA repair proteins, including p53 and BRCA2, has been visualized at three- and four-way junctions in DNA. The trombone model of DNA replication was directly verified, and the looping of DNA at telomeres was discovered.


Asunto(s)
Proteínas de Unión al ADN/ultraestructura , ADN/ultraestructura , Microscopía Electrónica/métodos , Nucleosomas/ultraestructura , Proteína BRCA2/metabolismo , Proteína BRCA2/ultraestructura , ADN/química , ADN/metabolismo , Replicación del ADN , Proteínas de Unión al ADN/metabolismo , Conformación de Ácido Nucleico , Nucleosomas/genética , Nucleosomas/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Proteína p53 Supresora de Tumor/ultraestructura
4.
Proteins ; 82(4): 668-78, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24150971

RESUMEN

Intrinsically disordered proteins (IDPs) are often characterized in terms of the hydrodynamic radius, Rh . The Rh of IDPs are known to depend on fractional proline content and net charge, where increased numbers of proline residues and increased net charge cause larger Rh . Though sequence and charge effects on the Rh of IDPs have been studied, the temperature sensitivity has been noted only briefly. Reported here are Rh measurements in the temperature range of 5-75°C for the intrinsically disordered N-terminal region of the p53 protein, p53(1-93). Of note, the Rh of this protein fragment was highly sensitive to temperature, decreasing from 35 Å at 5°C to 26 Å at 75°C. Computer generated simulations of conformationally dynamic and disordered polypeptide chains were performed to provide a hypothesis for the heat-induced compaction of p53(1-93) structure, which was opposite to the heat-induced increase in Rh observed for a model folded protein. The simulations demonstrated that heat caused Rh to trend toward statistical coil values for both proteins, indicating that the effects of heat on p53(1-93) structure could be interpreted as thermal denaturation. The simulation data also predicted that proline content contributed minimally to the native Rh of p53(1-93), which was confirmed by measuring Rh for a substitution variant that had all 22 proline residues changed for glycine.


Asunto(s)
Proteínas Intrínsecamente Desordenadas/química , Conformación Proteica , Proteína p53 Supresora de Tumor/química , Proteína p53 Supresora de Tumor/ultraestructura , Secuencia de Aminoácidos , Sustitución de Aminoácidos , Dicroismo Circular , Simulación por Computador , Electroforesis en Gel de Poliacrilamida , Glicina/química , Hidrodinámica , Interacciones Hidrofóbicas e Hidrofílicas , Proteínas Intrínsecamente Desordenadas/ultraestructura , Modelos Moleculares , Prolina/química , Pliegue de Proteína , Estructura Terciaria de Proteína , Temperatura
5.
PLoS Comput Biol ; 8(9): e1002682, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-23028280

RESUMEN

The unique ability of intrinsically disordered proteins (IDPs) to fold upon binding to partner molecules makes them functionally well-suited for cellular communication networks. For example, the folding-binding of different IDP sequences onto the same surface of an ordered protein provides a mechanism for signaling in a many-to-one manner. Here, we study the molecular details of this signaling mechanism by applying both Molecular Dynamics and Monte Carlo methods to S100B, a calcium-modulated homodimeric protein, and two of its IDP targets, p53 and TRTK-12. Despite adopting somewhat different conformations in complex with S100B and showing no apparent sequence similarity, the two IDP targets associate in virtually the same manner. As free chains, both target sequences remain flexible and sample their respective bound, natively [Formula: see text]-helical states to a small extent. Association occurs through an intermediate state in the periphery of the S100B binding pocket, stabilized by nonnative interactions which are either hydrophobic or electrostatic in nature. Our results highlight the importance of overall physical properties of IDP segments, such as net charge or presence of strongly hydrophobic amino acids, for molecular recognition via coupled folding-binding.


Asunto(s)
Modelos Químicos , Simulación de Dinámica Molecular , Factores de Crecimiento Nervioso/química , Factores de Crecimiento Nervioso/ultraestructura , Oligopéptidos/química , Proteínas S100/química , Proteínas S100/ultraestructura , Proteína p53 Supresora de Tumor/química , Proteína p53 Supresora de Tumor/ultraestructura , Secuencia de Aminoácidos , Sitios de Unión , Proteína CapZ , Simulación por Computador , Modelos Estadísticos , Datos de Secuencia Molecular , Método de Montecarlo , Fragmentos de Péptidos , Unión Proteica , Conformación Proteica , Subunidad beta de la Proteína de Unión al Calcio S100
6.
Nucleic Acids Res ; 39(20): 8960-71, 2011 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-21764777

RESUMEN

The p53 tumour suppressor is a transcriptional activator that controls cell fate in response to various stresses. p53 can initiate cell cycle arrest, senescence and/or apoptosis via transactivation of p53 target genes, thus preventing cancer onset. Mutations that impair p53 usually occur in the core domain and negate the p53 sequence-specific DNA binding. Moreover, these mutations exhibit a dominant negative effect on the remaining wild-type p53. Here, we report the cryo electron microscopy structure of the full-length p53 tetramer bound to a DNA-encoding transcription factor response element (RE) at a resolution of 21 A. While two core domains from both dimers of the p53 tetramer interact with DNA within the complex, the other two core domains remain available for binding another DNA site. This finding helps to explain the dominant negative effect of p53 mutants based on the fact that p53 dimers are formed co-translationally before the whole tetramer assembles; therefore, a single mutant dimer would prevent the p53 tetramer from binding DNA. The structure indicates that the Achilles' heel of p53 is in its dimer-of-dimers organization, thus the tetramer activity can be negated by mutation in only one allele followed by tumourigenesis.


Asunto(s)
ADN/química , Mutación , Proteína p53 Supresora de Tumor/química , Proteína p53 Supresora de Tumor/genética , Animales , Microscopía por Crioelectrón , ADN/ultraestructura , Ratones , Modelos Moleculares , Conformación de Ácido Nucleico , Unión Proteica , Estructura Terciaria de Proteína , Elementos de Respuesta , Proteína p53 Supresora de Tumor/ultraestructura
7.
Sci Rep ; 11(1): 19323, 2021 09 29.
Artículo en Inglés | MEDLINE | ID: mdl-34588591

RESUMEN

Despite the continuous discovery of host and guest proteins in membraneless organelles, complex host-guest interactions hinder the understanding of the molecular grammar governing liquid-liquid phase separation. In this study, we characterized the localization and dynamic properties of guest proteins in liquid droplets using single-molecule fluorescence microscopy. Eighteen guest proteins of different sizes, structures, and oligomeric states were examined in host p53 liquid droplets. Recruitment did not significantly depend on the structural properties of the guest proteins, but was moderately correlated with their length, total charge, and number of R and Y residues. In contrast, the diffusion of disordered guest proteins was comparable to that of host p53, whereas that of folded proteins varied widely. Molecular dynamics simulations suggest that folded proteins diffuse within the voids of the liquid droplet while interacting weakly with neighboring host proteins, whereas disordered proteins adapt their structures to form tight interactions with the host proteins. Our study provides insights into the key molecular principles of the localization and dynamics of guest proteins in liquid droplets.


Asunto(s)
Condensados Biomoleculares/química , Proteínas Intrínsecamente Desordenadas/química , Orgánulos/química , Condensados Biomoleculares/metabolismo , Condensados Biomoleculares/ultraestructura , Microscopía Fluorescente , Simulación de Dinámica Molecular , Mutación , Orgánulos/ultraestructura , Transición de Fase , Pliegue de Proteína , Multimerización de Proteína/genética , Imagen Individual de Molécula , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo , Proteína p53 Supresora de Tumor/ultraestructura
8.
Genes (Basel) ; 12(2)2021 02 15.
Artículo en Inglés | MEDLINE | ID: mdl-33672023

RESUMEN

P53, P63, and P73 proteins belong to the P53 family of transcription factors, sharing a common gene organization that, from the P1 and P2 promoters, produces two groups of mRNAs encoding proteins with different N-terminal regions; moreover, alternative splicing events at C-terminus further contribute to the generation of multiple isoforms. P53 family proteins can influence a plethora of cellular pathways mainly through the direct binding to specific DNA sequences known as response elements (REs), and the transactivation of the corresponding target genes. However, the transcriptional activation by P53 family members can be regulated at multiple levels, including the DNA topology at responsive promoters. Here, by using a yeast-based functional assay, we evaluated the influence that a G-quadruplex (G4) prone sequence adjacent to the p53 RE derived from the apoptotic PUMA target gene can exert on the transactivation potential of full-length and N-terminal truncated P53 family α isoforms (wild-type and mutant). Our results show that the presence of a G4 prone sequence upstream or downstream of the P53 RE leads to significant changes in the relative activity of P53 family proteins, emphasizing the potential role of structural DNA features as modifiers of P53 family functions at target promoter sites.


Asunto(s)
ADN/genética , G-Cuádruplex , Proteínas de la Membrana/genética , Proteína Tumoral p73/genética , Proteína p53 Supresora de Tumor/genética , Apoptosis/genética , Proteínas Reguladoras de la Apoptosis/genética , ADN/ultraestructura , Humanos , Proteínas de la Membrana/ultraestructura , Conformación de Ácido Nucleico , Regiones Promotoras Genéticas/genética , Proteínas Proto-Oncogénicas/genética , Elementos de Respuesta/genética , Saccharomyces cerevisiae/genética , Proteína Tumoral p73/ultraestructura , Proteína p53 Supresora de Tumor/ultraestructura
9.
Nat Commun ; 12(1): 2280, 2021 04 16.
Artículo en Inglés | MEDLINE | ID: mdl-33863900

RESUMEN

The tumor suppressor p53 is mutated in approximately half of all human cancers. p53 can induce apoptosis through mitochondrial membrane permeabilization by interacting with and antagonizing the anti-apoptotic proteins BCL-xL and BCL-2. However, the mechanisms by which p53 induces mitochondrial apoptosis remain elusive. Here, we report a 2.5 Å crystal structure of human p53/BCL-xL complex. In this structure, two p53 molecules interact as a homodimer, and bind one BCL-xL molecule to form a ternary complex with a 2:1 stoichiometry. Mutations at the p53 dimer interface or p53/BCL-xL interface disrupt p53/BCL-xL interaction and p53-mediated apoptosis. Overall, our current findings of the bona fide structure of p53/BCL-xL complex reveal the molecular basis of the interaction between p53 and BCL-xL, and provide insight into p53-mediated mitochondrial apoptosis.


Asunto(s)
Apoptosis/genética , Mitocondrias/fisiología , Proteína p53 Supresora de Tumor/ultraestructura , Proteína bcl-X/ultraestructura , Línea Celular Tumoral , Cristalografía por Rayos X , Humanos , Simulación del Acoplamiento Molecular , Mutación , Unión Proteica/genética , Multimerización de Proteína/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/ultraestructura , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/aislamiento & purificación , Proteína p53 Supresora de Tumor/metabolismo , Proteína bcl-X/genética , Proteína bcl-X/aislamiento & purificación , Proteína bcl-X/metabolismo
10.
Nat Commun ; 12(1): 7057, 2021 12 03.
Artículo en Inglés | MEDLINE | ID: mdl-34862374

RESUMEN

In response to genotoxic stress, the tumor suppressor p53 acts as a transcription factor by regulating the expression of genes critical for cancer prevention. Mutations in the gene encoding p53 are associated with cancer development. PRIMA-1 and eprenetapopt (APR-246/PRIMA-1MET) are small molecules that are converted into the biologically active compound, methylene quinuclidinone (MQ), shown to reactivate mutant p53 by binding covalently to cysteine residues. Here, we investigate the structural basis of mutant p53 reactivation by MQ based on a series of high-resolution crystal structures of cancer-related and wild-type p53 core domains bound to MQ in their free state and in complexes with their DNA response elements. Our data demonstrate that MQ binds to several cysteine residues located at the surface of the core domain. The structures reveal a large diversity in MQ interaction modes that stabilize p53 and its complexes with DNA, leading to a common global effect that is pertinent to the restoration of non-functional p53 proteins.


Asunto(s)
Antineoplásicos/farmacología , Compuestos Aza/farmacología , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Neoplasias/tratamiento farmacológico , Quinuclidinas/farmacología , Proteína p53 Supresora de Tumor/agonistas , Antineoplásicos/uso terapéutico , Compuestos Aza/química , Compuestos Aza/uso terapéutico , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Compuestos Bicíclicos Heterocíclicos con Puentes/uso terapéutico , Cristalografía por Rayos X , Humanos , Mutación con Pérdida de Función/efectos de los fármacos , Neoplasias/genética , Dominios Proteicos/efectos de los fármacos , Quinuclidinas/química , Quinuclidinas/uso terapéutico , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Proteínas Recombinantes/ultraestructura , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/aislamiento & purificación , Proteína p53 Supresora de Tumor/ultraestructura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA